Paper · 26909576
Cited by2,192
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,921 citations.
1 to 20 of 2,192
Download this page as JSON| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,979,207 | Liver-Lung Organotropism in Pancreatic Ductal Adenocarcinoma: A Five-Stage Framework. | Cancer Manag Res | 2026 | https://conductscience.org/library/papers/42979207 | PubMed |
| 42,978,795 | Machine learning models integrating 2D and 3D intratumoral heterogeneity features from multi-sequence MRI: accurate prediction of perineural invasion in pancreatic ductal adenocarcinoma. | Front Artif Intell | 2026 | https://conductscience.org/library/papers/42978795 | PubMed |
| 42,942,302 | BIMS-GA: Adaptive Multi-Objective Optimization for Network-Aware Pancreatic Ductal Adenocarcinoma Biomarker Discovery. | Life (Basel) | 2026 | https://conductscience.org/library/papers/42942302 | PubMed |
| 42,940,093 | Prognostic and Spatial Organization of Tertiary Lymphoid Structures in Pancreatic Ductal Adenocarcinoma. | Biomedicines | 2026 | https://conductscience.org/library/papers/42940093 | PubMed |
| 42,938,942 | Context-Dependent Spatial and Functional Roles of CD44 Across Pancreatic Ductal Adenocarcinoma States. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42938942 | PubMed |
| 42,938,908 | The Evolution of Oligometastatic Pancreatic Ductal Adenocarcinoma: From Anatomic Description to Biologically Informed Patient Selection. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42938908 | PubMed |
| 42,935,847 | Treating a systemic disease as a local one: failure points of current pancreatic cancer management and a multimodal, biology-guided framework for redesign. | Front Oncol | 2026 | https://conductscience.org/library/papers/42935847 | PubMed |
| 42,922,762 | Paternal regulation of H3K4 methylation supports tumor suppressor networks in mammals intergenerationally. | bioRxiv | 2026 | https://conductscience.org/library/papers/42922762 | PubMed |
| 42,898,383 | A MYC-LDHA-MCT4 expression program marks an SPP1/TREM2-centered macrophage state in pancreatic ductal adenocarcinoma. | Front Immunol | 2026 | https://conductscience.org/library/papers/42898383 | PubMed |
| 42,890,651 | Transcription factor-driven metabolic stratification reveals glycolytic and lipogenic subtypes with distinct prognostic and functional features in pancreatic cancer. | Front Oncol | 2026 | https://conductscience.org/library/papers/42890651 | PubMed |
| 42,870,132 | Driver mutation profiling by next-generation sequencing predicts survival and recurrence after curative-intent resection for pancreatic ductal adenocarcinoma: a genomic cohort study. | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/42870132 | PubMed |
| 42,869,988 | Clonal heterogeneity in human pancreatic ductal adenocarcinoma and its impact on tumor progression. | Nat Genet | 2026 | https://conductscience.org/library/papers/42869988 | PubMed |
| 42,866,405 | Beyond tumor biology: can host nutritional status refine prediction of early recurrence after pancreatic cancer surgery? | Gland Surg | 2026 | https://conductscience.org/library/papers/42866405 | PubMed |
| 42,858,298 | MVB Maturation Responsive to KRASG12D/TP53R175H Co-mutations Fuels Extracellular Vesicle-hypersecretion Phenotype to Aggravate Lymphangiogenesis and Lymphatic Metastasis. | J Extracell Vesicles | 2026 | https://conductscience.org/library/papers/42858298 | PubMed |
| 42,840,291 | Epigenetic dysregulation in pancreatic cancer: emerging biomarkers and clinical applications. | Front Epigenet Epigenom | 2025 | https://conductscience.org/library/papers/42840291 | PubMed |
| 42,836,735 | Pancreatic Cancer KRAS Breakthrough: Drug Graveyard No More. | Clin Cancer Res | 2026 | https://conductscience.org/library/papers/42836735 | PubMed |
| 42,832,147 | Radical Antegrade Modular Pancreatosplenectomy Versus Standard Resection in T3 Body and Tail Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Cohort Study. | Ann Surg Oncol | 2026 | https://conductscience.org/library/papers/42832147 | PubMed |
| 42,826,199 | Tumor cell-intrinsic stress states drive sensitivity to CAR T cell therapy in pancreatic cancer. | Sci Adv | 2026 | https://conductscience.org/library/papers/42826199 | PubMed |
| 42,824,914 | ApoA2 isoforms as blood-based biomarkers reflecting pancreatic exocrine dysfunction for risk stratification and perioperative management of pancreatic cancer. | Front Oncol | 2026 | https://conductscience.org/library/papers/42824914 | PubMed |
| 42,807,818 | Engineering strategies to address immune and delivery barriers in pancreatic ductal adenocarcinoma: a barrier-matched translational framework. | Front Immunol | 2026 | https://conductscience.org/library/papers/42807818 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/26909576/cited_by